Publication

Abstract : Stroke is currently the leading cause of neurological disability in adults. Two-thirds of stroke survivors have residual neurological deficits that impair their function, and approximately 50% are left with disabilities, making them dependent on others for activities of daily living. Albumin is said to be helpful in patient with acute ischemic stroke due to its antioxidant, hemodiltion, and neuroprotective effect. In this study, we correlated the serum Albumin level and functional outcome following the acute ischemic stroke. Hypoalbuminemia at admission may cause negative influences on neuroprotection in acute stroke patients. If this hypothesis is found to be true, treating patients having hypoalbuminemia in acute stroke might enhance their functional outcome.